リガーゼ酵素の世界市場レポート 2025年

リガーゼ酵素市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR12.0％で56億4,000万米ドルに成長します。予測期間の成長は、個別化医療アプリケーションの拡大、合成生物学への注目の高まり、医薬品開発におけるリガーゼ酵素の採用、分子診断の需要増加、次世代シーケンサーにおけるリガーゼの統合に起因すると考えられます。予測期間における主な動向としては、特定の用途に向けた人工リガーゼの開発、CRISPRベース技術へのリガーゼ酵素の統合、研究・診断用リガーゼベースアッセイのカスタマイズ、リガーゼベースの等温増幅法の台頭、診断アッセイへのリガーゼ連鎖反応（LCR）の採用などが挙げられます。

がんや遺伝性疾患の罹患率の上昇が、今後数年間のリガーゼ酵素市場の成長を牽引すると予想されます。がんは、異常な細胞の無秩序な増殖と拡散によって特徴づけられる様々な疾患を包含し、一方、遺伝性疾患は、個人の遺伝物質、特にDNAの異常や変異によって引き起こされる様々な病状を含みます。リガーゼ酵素はDNAの複製、修復、組換えにおいて重要な役割を果たしています。がんの場合、リガーゼは傷ついたDNAの修復を促進し、細胞の無秩序な増殖の一因となります。さらに、リガーゼは遺伝的障害に罹患した細胞を標的とし、排除するために使用されることもあります。例えば、2024年7月にオーストラリア保健福祉研究所から発表された報告書によると、オーストラリアで診断されたがん患者は、2022年の160,570人から2023年には164,694人へと増加しています。この動向は、10万人当たり403人の新規がん患者と144人のがん関連死亡者という統計が示すように、オーストラリアにおけるがんの有病率の増加を強調するものです。さらに、登録慈善団体ジーン・ピープルUKが2023年2月に発表した報告書によると、英国では約25人に1人の子供が遺伝的疾患に罹患しており、その結果、240万人以上が遺伝的疾患を抱えて生活しているといいます。毎年、約3万人の赤ちゃんと子供が新たに診断されています。このように、がんと遺伝性疾患の有病率の増加が、リガーゼ酵素市場の成長を後押ししています。

研究開発（R&D）活動の増加は、今後数年間のリガーゼ酵素市場の成長を促進すると予測されます。研究開発には、企業や組織が既存の製品やプロセスを強化したり、新しいものを生み出したりするために行う調査活動が含まれます。一般にDNAリガーゼと呼ばれるリガーゼ酵素は、DNA分子を結合させるのに不可欠であり、多方面にわたる様々な研究開発活動に欠かせないツールとなっています。例えば、2024年4月に国家統計局が発表した報告書によると、英国政府の研究開発に対する純支出（EUへの拠出を除く）は2022年に155億ポンド（193億7,500万米ドル）に上り、2021年の140億ポンド（175億米ドル）から10.5％増加しました。さらに、2022年には、EUからの拠出金と知識移転活動を含む研究開発への純支出総額は164億ポンド（205億米ドル）に達し、2021年の150億ポンド（187億5,000万米ドル）から8.9%増加しました。その結果、研究開発活動の活発化がリガーゼ酵素市場の成長を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界リガーゼ酵素 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のリガーゼ酵素市場：成長率分析
• 世界のリガーゼ酵素市場の実績：規模と成長, 2019-2024
• 世界のリガーゼ酵素市場の予測：規模と成長, 2024-2029, 2034F
• 世界リガーゼ酵素総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のリガーゼ酵素市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 大腸菌DNAリガーゼ
• T4 DNAリガーゼ
• 哺乳類リガーゼ
• 耐熱性リガーゼ
• 世界のリガーゼ酵素市場：ソース別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 微生物
• 動物
• 植物
• 世界のリガーゼ酵素市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• リガーゼ連鎖反応（LCR）
• リガーゼ検出反応（LDR）
• 次世代シーケンシング（NGS）
• 繰り返し拡張検出（RED）
• ローリングサークルアンプ（RCA）
• 近接ライゲーションアッセイ（PLA）
• 分子クローニング
• ライゲーション媒介PCR
• 突然変異検出
• 世界のリガーゼ酵素市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 調査機関および研究所
• 製薬およびバイオ医薬品企業
• 診断検査室
• 世界のリガーゼ酵素市場、大腸菌DNAリガーゼのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• リガーゼI
• リガーゼII
• 世界のリガーゼ酵素市場、T4 DNAリガーゼのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 野生型T4リガーゼ
• 改変T4リガーゼ
• 世界のリガーゼ酵素市場、哺乳類リガーゼのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• リガーゼIV
• リガーゼI
• 世界のリガーゼ酵素市場、熱安定性リガーゼのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• Taq DNAリガーゼ
• ピロコッカス・フリオサスリガーゼ

第7章 地域別・国別分析

• 世界のリガーゼ酵素市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のリガーゼ酵素市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• リガーゼ酵素市場：競合情勢
• リガーゼ酵素市場：企業プロファイル
  • BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Illumina Inc.
• QIAGEN N.V.
• GenScript
• Promega Corporation
• Oxford Nanopore Technologies Limited
• Takara Bio Inc.
• New England Biolabs Inc.
• BioVision Inc.
• Enzo Life Sciences
• Zymo Research
• LGC Biosearch Technologies
• Genetix Biotech Asia Pvt. Ltd.
• BLIRT S.A.
• Jena Bioscience
• Bioline

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• リガーゼ酵素市場2029：新たな機会を提供する国
• リガーゼ酵素市場2029：新たな機会を提供するセグメント
• リガーゼ酵素市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Ligase enzymes, a class of proteins essential for facilitating the union of two DNA strands, play a pivotal role in biotechnology and pharmaceuticals. Their significance extends to various cellular processes, notably DNA replication and protein synthesis.

Key types of ligase enzyme products include E. coli DNA ligase, T4 DNA ligase, mammalian ligases, and thermostable ligases. E. coli DNA ligase specifically refers to an enzyme sourced from Escherichia coli (E. coli) bacteria. These ligases are derived from diverse organisms, including microorganisms, animals, and plants. They are integral to a multitude of techniques, encompassing ligase chain reaction (LCR), ligase detection reaction (LDR), next-generation sequencing (NGS), repeat expansion detection (RED), rolling circle amplification (RCA), proximity ligation assay (PLA), molecular cloning, ligation-mediated PCR, and mutation detection. These versatile applications cater to a broad spectrum of end-users, including research laboratories and institutions, pharmaceutical and biopharmaceutical companies, as well as diagnostic laboratories.

The ligases enzyme market research report is one of a series of new reports from The Business Research Company that provides ligases enzyme market statistics, including ligases enzyme industry global market size, regional shares, competitors with a ligases enzyme market share, detailed ligases enzyme market segments, market trends and opportunities, and any further data you may need to thrive in the ligases enzyme industry. This ligases enzyme market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ligases enzyme market size has grown rapidly in recent years. It will grow from $3.23 billion in 2024 to $3.58 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to the initial discovery and development of ligase enzymes, growth of the biotechnology industry, increased understanding of DNA repair mechanisms, expansion of genetic engineering applications, and rise in demand for molecular diagnostics

The ligases enzyme market size is expected to see rapid growth in the next few years. It will grow to $5.64 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to the expansion of personalized medicine applications, growing focus on synthetic biology, adoption of ligase enzymes in drug development, increased demand for molecular diagnostics, and integration of ligases in next-generation sequencing. Major trends in the forecast period include the development of engineered ligases for specific applications, integration of ligase enzymes in CRISPR-based technologies, customization of ligase-based assays for research and diagnostics, rise of ligase-based isothermal amplification methods, adoption of ligase chain reaction (LCR) in diagnostic assays.

The rising incidence of cancer and genetic disorders is anticipated to drive the growth of the ligase enzyme market in the coming years. Cancer encompasses a range of diseases marked by the uncontrolled proliferation and spread of abnormal cells, while genetic disorders involve various medical conditions caused by abnormalities or mutations in an individual's genetic material, particularly DNA. Ligase enzymes play a crucial role in DNA replication, repair, and recombination. In the context of cancer, ligases facilitate the repair of damaged DNA, which can contribute to the unchecked growth of cells. Additionally, ligases can be employed to target and eliminate cells affected by genetic disorders. For instance, a report from the Australian Institute of Health and Welfare in July 2024 indicated an increase in diagnosed cancer cases in Australia, from 160,570 in 2022 to 164,694 in 2023, showcasing a significant rise over the year. This trend underscores the growing prevalence of cancer in the nation, with statistics revealing 403 new cancer cases and 144 cancer-related deaths per 100,000 individuals. Furthermore, a February 2023 report by Gene People UK, a registered charity organization, stated that approximately 1 in 25 children in the UK are affected by a genetic condition, resulting in over 2.4 million individuals living with a genetic disorder. Annually, around 30,000 babies and children are newly diagnosed. Thus, the increasing prevalence of cancer and genetic disorders is propelling the growth of the ligase enzyme market.

An increase in research and development (R&D) activities is projected to drive the growth of the ligase enzyme market in the coming years. R&D encompasses the investigative efforts undertaken by companies or organizations to enhance existing products and processes or to create new ones. Ligase enzymes, commonly referred to as DNA ligases, are vital for joining DNA molecules together, making them indispensable tools for various R&D activities across multiple fields. For instance, a report from the Office for National Statistics in April 2024 revealed that the UK government's net expenditure on R&D (excluding contributions to the EU) rose to £15.5 billion ($19.375 billion) in 2022, reflecting a 10.5% increase from £14.0 billion ($17.5 billion) in 2021. Furthermore, in 2022, the total net expenditure on R&D, which included EU contributions and knowledge transfer activities, reached £16.4 billion ($20.5 billion), signifying an 8.9% increase from £15.0 billion ($18.75 billion) in 2021. Consequently, the rise in research and development activities is fueling the growth of the ligase enzyme market.

Major companies in the ligases enzyme market are advancing technologies like nanopore technologies to enhance the precision and efficiency of DNA sequencing and manipulation, thereby improving applications in genomics, synthetic biology, and personalized medicine. Nanopore technologies use nanopores to detect and analyze molecules, such as DNA or proteins, by measuring changes in ionic current as these molecules pass through the pore. For example, in February 2023, Eurofins Genomics, a US-based biotechnology firm, introduced the Express Oxford Nanopore Sequencing service. This service leverages Oxford Nanopore technology, enabling the sequencing of long DNA fragments. Such capabilities are especially advantageous for comprehensive genomic analyses, including metagenomics and structural variant detection.

Major companies in the ligases enzyme market are advancing technologies like the SAN HQ 2.0 enzyme to improve the efficiency and precision of nucleic acid manipulation in biomanufacturing processes. The SAN HQ 2.0 enzyme is specifically designed for biomanufacturing, effectively eliminating residual nucleic acids to enhance the purity and safety of processes such as viral vector production. For example, in December 2022, ArcticZymes Technologies ASA, a biotechnology firm based in Norway, launched the SAN HQ 2.0. This new product includes the SAN HQ 2.0 ELISA Kit, which represents a significant enhancement to ArcticZymes Technologies' portfolio. It demonstrates their commitment to providing reliable tools for quality control and compliance in biomanufacturing processes. This development not only addresses current industry demands but also positions ArcticZymes competitively in a market that prioritizes innovation and efficiency in bioprocessing.

In May 2022, QIAGEN N.V., a Germany-based provider of molecular testing solutions, acquired a majority stake in BLIRT S.A., a Poland-based biotechnology company known for manufacturing specialty ligase enzymes and reagents. This strategic acquisition is aimed at expanding QIAGEN's sample technology business by leveraging BLIRT's technology and expertise, thereby reinforcing QIAGEN's position in the life science industry. This strategic maneuver underscores the importance of inorganic growth strategies for gaining a competitive edge in the dynamic ligase enzyme market.

Major companies operating in the ligases enzyme market include BASF SE, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., GenScript, Promega Corporation, Oxford Nanopore Technologies Limited, Takara Bio Inc., New England Biolabs Inc., BioVision Inc., Enzo Life Sciences, Zymo Research, LGC Biosearch Technologies, Genetix Biotech Asia Pvt. Ltd., BLIRT S.A., Jena Bioscience, Bioline, Creative Enzymes, ArcticZymes Technologies ASA

North America was the largest region in the ligases enzyme market in 2024. Asia-Pacific is expected to be the fastest-growing region in the ligases enzyme market report during the forecast period. The regions covered in the ligases enzyme market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ligases enzyme market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ligases enzyme market consists of sales of hi-t4 DNA ligase, splintR ligase, salt-t4 DNA ligase, t7 DNA ligase, quick ligation kits, Taq DNA ligase, and electroLigase. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ligases Enzyme Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ligases enzyme market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ligases enzyme ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ligases enzyme market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: E. coli DNA ligase; T4 DNA Ligase; Mammalian Ligases; Thermostable Ligases
• 2) By Source: Microorganisms; Animal; Plant
• 3) By Application: Ligase Chain Reaction (LCR); Ligase Detection Reaction (LDR); Next-Generation Sequencing (NGS); Repeat Expansion Detection (RED); Rolling Circle Amplification (RCA); Proximity Ligation Assay (PLA); Molecular Cloning; Ligation Mediated PCR; Mutation Detection
• 4) By End-User: Research Laboratories And Institutions; Pharmaceutical And Biopharmaceutical Companies; Diagnostic Laboratories
• Subsegments:
• 1) By E. coli DNA Ligase: Ligase I; Ligase II
• 2) By T4 DNA Ligase: Wild-Type T4 Ligase; Modified T4 Ligase
• 3) By Mammalian Ligases: Ligase IV; Ligase I
• 4) By Thermostable Ligases: Taq DNA Ligase; Pyrococcus Furiosus Ligase
• Companies Mentioned: BASF SE; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Merck KGaA; Agilent Technologies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ligases Enzyme Market Characteristics

3. Ligases Enzyme Market Trends And Strategies

4. Ligases Enzyme Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Ligases Enzyme Growth Analysis And Strategic Analysis Framework

• 5.1. Global Ligases Enzyme PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Ligases Enzyme Market Growth Rate Analysis
• 5.4. Global Ligases Enzyme Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Ligases Enzyme Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Ligases Enzyme Total Addressable Market (TAM)

6. Ligases Enzyme Market Segmentation

• 6.1. Global Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• E. coli DNA ligase
• T4 DNA Ligase
• Mammalian Ligases
• Thermostable Ligases
• 6.2. Global Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microorganisms
• Animal
• Plant
• 6.3. Global Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ligase Chain Reaction (LCR)
• Ligase Detection Reaction (LDR)
• Next-Generation Sequencing (NGS)
• Repeat Expansion Detection (RED)
• Rolling Circle Amplification (RCA)
• Proximity Ligation Assay (PLA)
• Molecular Cloning
• Ligation Mediated PCR
• Mutation Detection
• 6.4. Global Ligases Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research Laboratories And Institutions
• Pharmaceutical And Biopharmaceutical Companies
• Diagnostic Laboratories
• 6.5. Global Ligases Enzyme Market, Sub-Segmentation Of E. coli DNA Ligase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ligase I
• Ligase II
• 6.6. Global Ligases Enzyme Market, Sub-Segmentation Of T4 DNA Ligase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wild-Type T4 Ligase
• Modified T4 Ligase
• 6.7. Global Ligases Enzyme Market, Sub-Segmentation Of Mammalian Ligases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ligase IV
• Ligase I
• 6.8. Global Ligases Enzyme Market, Sub-Segmentation Of Thermostable Ligases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Taq DNA Ligase
• Pyrococcus Furiosus Ligase

7. Ligases Enzyme Market Regional And Country Analysis

• 7.1. Global Ligases Enzyme Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Ligases Enzyme Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ligases Enzyme Market

• 8.1. Asia-Pacific Ligases Enzyme Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ligases Enzyme Market

• 9.1. China Ligases Enzyme Market Overview
• 9.2. China Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ligases Enzyme Market

• 10.1. India Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ligases Enzyme Market

• 11.1. Japan Ligases Enzyme Market Overview
• 11.2. Japan Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ligases Enzyme Market

• 12.1. Australia Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ligases Enzyme Market

• 13.1. Indonesia Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ligases Enzyme Market

• 14.1. South Korea Ligases Enzyme Market Overview
• 14.2. South Korea Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ligases Enzyme Market

• 15.1. Western Europe Ligases Enzyme Market Overview
• 15.2. Western Europe Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ligases Enzyme Market

• 16.1. UK Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ligases Enzyme Market

• 17.1. Germany Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ligases Enzyme Market

• 18.1. France Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ligases Enzyme Market

• 19.1. Italy Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ligases Enzyme Market

• 20.1. Spain Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ligases Enzyme Market

• 21.1. Eastern Europe Ligases Enzyme Market Overview
• 21.2. Eastern Europe Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ligases Enzyme Market

• 22.1. Russia Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ligases Enzyme Market

• 23.1. North America Ligases Enzyme Market Overview
• 23.2. North America Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ligases Enzyme Market

• 24.1. USA Ligases Enzyme Market Overview
• 24.2. USA Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ligases Enzyme Market

• 25.1. Canada Ligases Enzyme Market Overview
• 25.2. Canada Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ligases Enzyme Market

• 26.1. South America Ligases Enzyme Market Overview
• 26.2. South America Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ligases Enzyme Market

• 27.1. Brazil Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ligases Enzyme Market

• 28.1. Middle East Ligases Enzyme Market Overview
• 28.2. Middle East Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ligases Enzyme Market

• 29.1. Africa Ligases Enzyme Market Overview
• 29.2. Africa Ligases Enzyme Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Ligases Enzyme Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Ligases Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ligases Enzyme Market Competitive Landscape And Company Profiles

• 30.1. Ligases Enzyme Market Competitive Landscape
• 30.2. Ligases Enzyme Market Company Profiles
  • 30.2.1. BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Ligases Enzyme Market Other Major And Innovative Companies

• 31.1. Illumina Inc.
• 31.2. QIAGEN N.V.
• 31.3. GenScript
• 31.4. Promega Corporation
• 31.5. Oxford Nanopore Technologies Limited
• 31.6. Takara Bio Inc.
• 31.7. New England Biolabs Inc.
• 31.8. BioVision Inc.
• 31.9. Enzo Life Sciences
• 31.10. Zymo Research
• 31.11. LGC Biosearch Technologies
• 31.12. Genetix Biotech Asia Pvt. Ltd.
• 31.13. BLIRT S.A.
• 31.14. Jena Bioscience
• 31.15. Bioline

32. Global Ligases Enzyme Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ligases Enzyme Market

34. Recent Developments In The Ligases Enzyme Market

35. Ligases Enzyme Market High Potential Countries, Segments and Strategies

• 35.1 Ligases Enzyme Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Ligases Enzyme Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Ligases Enzyme Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer